An important message regarding the current COVID-19 pandemic. Click here to read more.


More fever


More patients with fever. However, not all cases of fever are created equal ….

  1. Artesunate
  2. Atovaquone-proguanil
  3. Cerebral malaria
  4. Chloroquine
  5. Chloroquine-resistant malaria
  6. Malaria
  7. Malaria Prophylaxis
  8. Malaria prophylaxis during pregnancy
  9. Mefloquine
  10. Plasmodium falciparum - diagnosis and treatment
  11. Primaquine
  1. BAGGISH AL, HILL DR. Antiparasitic Agent Atovaquone Antimicrob Agents Chemother [online] 2002/05/01 00:00, 46(5):1163-1173 [viewed 26 April 2016] Available from: doi:10.1128/AAC.46.5.1163-1173.2002
  2. BRAGA CáSSIO BRAGA E, MARTINS ANTONIO CAMARGO, CAYOTOPA ATHAID DAVID ESCALANTE, KLEIN WAGNER WERNER, SCHLOSSER ANDREUS ROBERTO, SILVA ALINE FERREIRA DA, SOUZA MARDELSON NERY DE, ANDRADE BRENO WILSON BENEVIDES, FILGUEIRA-JúNIOR JOSé ALCâNTARA, PINTO WAGNER DE JESUS, DA SILVA-NUNES MôNICA. Side Effects of Chloroquine and Primaquine and Symptom Reduction in Malaria Endemic Area (Mâncio Lima, Acre, Brazil). Interdisciplinary Perspectives on Infectious Diseases [online] 2015 December, 2015:1-7 [viewed 26 April 2016] Available from: doi:10.1155/2015/346853
  3. CASTELLI FRANCESCO, ODOLINI SILVIA, AUTINO BEATRICE, FOCA EMANUELE, RUSSO ROSARIO. Malaria Prophylaxis: A Comprehensive Review. Pharmaceuticals [online] 2010 October, 3(10):3212-3239 [viewed 26 April 2016] Available from: doi:10.3390/ph3103212
  4. CHEN CHANG. Development of antimalarial drugs and their application in China: a historical review. Array [online] 2014 December [viewed 26 April 2016] Available from: doi:10.1186/2049-9957-3-9
  5. FOLEY M, TILLEY L. Quinoline antimalarials: mechanisms of action and resistance. Int J Parasitol [online] 1997 Feb, 27(2):231-40 [viewed 26 April 2016] Available from:
  6. FREEDMAN DAVID O.. Malaria Prevention in Short-Term Travelers. N Engl J Med [online] 2008 August, 359(6):603-612 [viewed 25 April 2016] Available from: doi:10.1056/NEJMcp0803572
  7. MARKS M, GUPTA-WRIGHT A, DOHERTY JF, SINGER M, WALKER D. Managing malaria in the intensive care unit Br J Anaesth [online] 2014/12/01 00:00, 113(6):910-921 [viewed 22 April 2016] Available from: doi:10.1093/bja/aeu157
  8. RITCHIE EC, BLOCK J, NEVIN RL. Psychiatric side effects of mefloquine: applications to forensic psychiatry. J Am Acad Psychiatry Law [online] 2013, 41(2):224-35 [viewed 26 April 2016] Available from:
  9. SAHU PRAVEEN K., SATPATHI SANGHAMITRA, BEHERA PRATIVA K., MISHRA SAROJ K., MOHANTY SANJIB, WASSMER SAMUEL CROCODILE. Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches. Front. Cell. Infect. Microbiol. [online] 2015 October [viewed 22 April 2016] Available from: doi:10.3389/fcimb.2015.00075
  10. SAIFI ALAM. Antimalarial drugs: Mode of action and status of resistance. Afr. J. Pharm. Pharmacol. [online] 2013 February, 7(5):148-156 [viewed 26 April 2016] Available from: doi:10.5897/AJPPX12.015
  11. TANGPUKDEE N, DUANGDEE C, WILAIRATANA P, KRUDSOOD S. Malaria Diagnosis: A Brief Review Korean J Parasitol [online] 2009/06/01 00:00, 47(2):93-102 [viewed 26 April 2016] Available from: doi:10.3347/kjp.2009.47.2.93
  12. WAHEED ANAM A, GHANCHI NAJIA K, REHMAN KARIM A, RAZA AFSHEEN, MAHMOOD SYED F, BEG MOHAMMAD A. Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat. Malar J [online] December [viewed 26 April 2016] Available from: doi:10.1186/s12936-015-0660-0
  13. WELLEMS THOMAS E., PLOWE CHRISTOPHER V.. Chloroquine‐Resistant Malaria. J INFECT DIS [online] 2001 September, 184(6):770-776 [viewed 26 April 2016] Available from: doi:10.1086/322858